Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat

Free Radical Biology and Medicine

Volumn 20, Issue 1, 1996, Pages 53-61

  De La Cruz, Cristina P ^a   Revilla, Elisa ^a   Venero, Jose Luis ^a   Ayala, Antonio ^a   Cano, Josefina ^a   Machado, Alberto ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Aging; Carbonyl groups; Free radicals; Oxidative damage; Striatum; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

CARBONYL DERIVATIVE; FREE RADICAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROGEN PEROXIDE; NEUROFILAMENT PROTEIN; TYROSINE 3 MONOOXYGENASE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; MALE; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0030065155     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(95)02025-X     Document Type: Article

References (52)

1. Agnati, L. F.; Fuxe, K.; Benfenati, F.; Toffano, G.; Cimino, M.; Calza, L.; Battistine, N.; Pich, E. M. Computer-assisted morphometry and microdensitometry of transmitter-identified neurons with special reference to the mesostriatal dopamine pathway: III. Studies on aging processes. Acta. Physiol. Scand. Suppl. 352:45-64; 1984.
2. Finch, C. E.; Morgan, D. G. RNA and protein metabolism in the aging brain. Annu. Rew. Neurosci. 13:75-87; 1990.
3. Finch, C. E. Age-related changes in brain catecholamines: A synopsis of findings in C57BL/6J mice and other models. In: Finch, C. E.; Potter, D. E.; Kenny, A. D., eds. Advances in experimental medicine and biology, Parkinson's disease: II. Aging and neuroendocrine relationships, Vol 113. New York: Plenum; 1981:15-39.
4. Machado, A.; Cano, J.; Santiago, M. The change with age in biogenic amines and their metabolites in the striatum of the rat. Arch. Gerontol. Geriatr. 5:333-342; 1986.
5. Venero, J. L.; Machado, A.; Cano, J. Changes in monoamines and their metabolites in substantia nigra of aged rats. Mech. Ageing Dev. 49:227-233; 1989.
6. Venero, J. L.; Machado, A.; Cano, J. Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats. J. Neurochem. 56:1940-1948; 1991.
7. Venero, J. L.; Machado, A.; Cano, J. Age affects on monoamine turnover of the rat substantia nigra. Brain Res. 557:109-114; 1991.
8. McGeer, P. L.; Itagakj, S.; Akiyama, H.; McGeer, E. G. Rate of cell death in Parkinsonism indicates active neuropathological process. Ann. Neurol. 24:574-576; 1988.
9. McGeer, P. L.; McGeer, E. G.; Suzuki, J. S. Aging and extrapyramidal function. Arch. Neurol. 34:33-35; 1977.
10. Tatton, W. G.; Greenwood, C. E.; Salo, P. T.; Seniuk, N. A. Transmitter synthesis increases in substantia nigra neurons of the aged mouse. Neurosci. Letters. 131:179-182; 1991.
11. Irwin, I.; Delanney, L. E.; Mcneill, T.; Chan, P.; Forno, L. S.; Murphy, G. M.; Dimonte, D. A.; Sandy, M. S.; Langston, J. W. Aging and the nigrostriatal dopamine system: A nonhuman primate study. Neurodegeneration 3:251-265; 1994.
12. McNeill, T. H.; Koek, L. L. Differential effects of advancing age on neurotransmitter cell loss in the substantia nigra and striatum of C57BL/6N mice. Brain Res. 521:107-117; 1990.
13. Bernheimer, H.; Birkmayer, W.; Hornykiewicz, O.; Jellinger, K.; Seitelberger, F. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlation. J. Neurol. Sci. 20:415-455; 1973.
14. Ehringer, H.; Hornykiewic, O. Verteilung von noradrenalin und dopamin (3-Hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin. Wochenschr. 38:1236-1239; 1960.
15. Wolf, M. E.; LeWitt, P. A.; Bannon, M. J.; Dragovic, L. J.; Kapatos, G. Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate. J. Neurochem. 56:1191-1200; 1991.
16. Harman, D. The aging process. Proc. Natl. Acad. Sci. USA 78:7124-7128; 1981.
17. Adams, J. D.; Odunze, I. N. Oxygen free radicals and Parkinson's disease. Free Radic. Biol. Med. 10:161-169; 1991.
18. Ben-Shachar, D.; Riederer, P.; Youdim, M. B. H. Iron-melanin interaction and lipid peroxidation; Implication for Parkinson's disease. J. Neurochem. 57:1609-1614; 1991.
19. Poirier, J.; Kogan, S.; Gauthier, S. Environment, genetics and idiopathic Parkinson's disease. Can. J. Neurol. Sci. 18:70-76; 1991.
20. Volicer, L.; Crino, P. B. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiol. Aging. 11:567-571; 1990.
21. Ahn, B.; Rhee, S. G.; Stadtman, E. R. Use of fluorescein hydrazide and fluorescein thiosemicarbazide reagents for the fluorometric determination of protein carbonyl groups and for the detection of oxidized protein on polyacrylamide gels. Anal. Biochem. 161:245-257; 1987.
22. Lamour, Y.; Dutar, P.; Jobert, A. Septo-hippocampal neurons: Altered properties in the aged rat. Brain Res. 416:277-282; 1987.
23. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.
24. Carlsson, A.; Davis, J. N.; Kehr, W.; Lindqvist, M.; Atack, C. V. A. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch. Pharmacol. 275:153-168; 1972.
25. Korf, J. Turnover rate assessments of cerebral neurotransmitter amines and acetylcholine. In: Boulton, A. A.; Baker, J. M., eds. Neuromethods. Vol. 2. Clifton, NJ: Humana Press; 1985:407-456.
26. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
27. Mogi, M.; Harada, M.; Kojima, K.; Kiuchi, K.; Nagatsu, I.; Nagatsu, T. Effects of repeated systemic administration of 1-methyl-4 phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content. Neurosci. Lett. 80:213-218; 1987.
28. Lenz, A. G.; Costabel, U.; Shaltiel, S.; Levine, R. L. Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride. Anal. Biochem. 177:419-425; 1989.
29. 2O and absorption of (3H)tyrosine by charcoal. Life Sci. 39:2185-2189; 1986.
30. Laemmli, U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685; 1970.
31. Fine, M. I.; Masserano, J. M.; Weiner, N. The effects of reserpine and haloperidol on tyrosine hydroxylase in the brains of aged rat. Life Sci. 39:235-241; 1986.
32. McGeer, E.; McGeer, P. L. Neurotransmitter metabolism in the aging brain. In: Terry, R. D.; Gerson, S., eds. Neurobiology of aging. New York: Raven Press; 1976:389-403.
33. O'Callaghan, J. P.; Miller, D. B. The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain. Neurobiol. Aging. 12:171-174; 1991.
34. Nichols, N. R.; Day, J. R.; Laping, N. J.; Johnson, S. A.; Finch, C. E. GFAP messenger-RNA increases with age in rat and human brain. Neurobiol. Aging. 14:421-429; 1993.
35. Levine, L. R. Oxidative modification of glutamine synthetase. J. Biol. Chem. 258:11828-11833; 1983.
36. Haavik, J.; Le Bourdelles, B.; Martinez, A.; Flatmark, T.; Mallet, J. Recombinant human tyrosine hydroxylase isoenzymes. Reconstitution with iron and inhibitory effect of other metal ions. Eur. J. Biochem. 199:371-378; 1991.
37. Halliwell, B. Reactive oxygen species and central nervous system. J. Neurochem. 29:1609-1623; 1992.
38. Ames, B. H.; Shigenaga, M. K.; Hagen, T. M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90:7915-7922; 1993.
39. Fando, J. L.; Salinas, M.; Wasterlain, C. G. Age-dependent changes in brain protein synthesis in the rat. Neurochem. Res. 5:373-383; 1980.
40. Gordillo, E.; Ayala, A.; Bautista, J.; Machado, A. Implication of lysine residues in the loss of enzymatic activity in rat liver 6-phosphogluconate dehydrogenase found in aging. J. Biol. Chem. 264:17024-17028; 1989.
41. Gordillo, E.; Ayala, A.; F-Lobato, M.; Bautista, J.; Machado, A. Possible involvement of histidine residues in the loss of enzymatic activity of rat liver malic enzyme during aging. J. Biol. Chem. 263:8053-8057; 1988.
42. Machado, A.; Ayala, A.; Gordillo, E.; Revilla, E.; Santa Maria, C. Relationship between enzymatic activity loss and post-translational protein modification in aging. Arch. Gerontol. Geriatr. 12:187-197; 1991.
43. Stadtman, E. R. Oxidation of proteins by mixed-function oxidation system: Implication in protein turnover: Aging and neutrophil function. Trends Biochem. Sci. 11:11-12; 1986.
44. Stadtman, E. R. Protein oxidation and aging. Science 257:1220-1224; 1993.
45. Riederer, P.; Wuketich, S. Time course of nigrostriatal degeneration in Parkinson's disease J. Neural. Transm. 38:277-301; 1976.
46. Uchihara, T.; Kondo, H.; Kosaka, K.; Tsukagoshi, H. Selective loss of nigral neurons in Alzheimer's disease: A morphometric study. Acta Neuropathol. 83:271-276; 1992.
47. Uchihara, T.; Tsuchiya, K.; Kosaka, K. Selective loss of nigral neurons in Pick's disease: A morphometric study. Acta Neuropathol. 81:155-161; 1990.
48. Oyanagi, K.; Takeda, S.; Takahashi, H.; Ohama, E.; Ikuta, F. A quantitative investigation of the substantia nigra in Huntington's disease. Ann Neurol. 26:13-19; 1989.
49. Murray, A. M.; Wehmueller, F. B.; Marshall, J. F.; Hurtig, H. I.; Gottleib, G. L.; Joyce, J. N. Damage to dopamine systems differs between Parkinsons-disease and Alzheimers-disease with parkinsonism. Ann Neurol. 37:300-312; 1995.
50. Rosen, D. R.; Siddique, T. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:59-62; 1993.
51. Wol, H. K.; Crain, B. J.; Siddique, T. Degeneration of substantia nigra in familial amyotrophic lateral sclerosis. Clin. Neuropath. 10:291-296; 1991.
52. Kato, S.; Oda, M.; Tanabe, H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 19:300-304; 1993.